Emapalumab | m-entrepreneurship.com

Product Name :
Emapalumab

Search keywords :
Emapalumab

drugId :
null

Target Vo:
Interferon gamma

Target Vo Short Name :
IFN-γ

Moa_Name:
Interferon gamma inhibitors

First Approval Country :
United States

First Approval Date Filter:
2018

Origin Company_Name :
Novimmune Sa

Active Company_Name :
Novimmune Sa

Active Indication_Name:
Lymphohistiocytosis, Hemophagocytic

In Active Indication_Name:
Immune System Diseases

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Carbonic Anhydrase I Antibody
Phospho-NF-κB p65 (Ser529) Antibody
Thrombomodulin Antibody (YA891): Thrombomodulin Antibody (YA891) is an unconjugated, approximately 95 kDa, rabbit-derived, anti-Thrombomodulin (YA891) monoclonal antibody. Thrombomodulin Antibody (YA891) can be used for: WB, ICC/IF, IP expriments in human background without labeling.

Author: Betaine hydrochloride

Related Posts